Indies Pharma Jamaica Limited

INDIES

JME201800161

Pharmaceuticals

End-of-day quote JAMAICA STOCK EXCHANGE Other stock markets 06:00:00 2024-06-26 pm EDT			5-day change	1st Jan Change
2.65 ^JMD	0.00%		+1.53%	-14.24%

Jun. 17	Indies Pharma Jamaica Limited Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	CI
Mar. 14	Indies Pharma Jamaica Limited Reports Earnings Results for the First Quarter Ended January 31, 2024	CI

INDIES PHARMA JAMAICA : Disclosure of ANDA filing at USFDA, A Paragraph IV Filing and Patent Amendment

June 14, 2023 at 03:56 pm EDT

June 14, 2023
2:46 pm

SKM_284e23061507030Download

Attachments

Original Link
Original Document
Permalink

Disclaimer

Indies Pharma Jamaica Ltd. published this content on 14 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2023 19:55:04 UTC.

Latest news about Indies Pharma Jamaica Limited

Indies Pharma Jamaica Limited Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	Jun. 17	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the First Quarter Ended January 31, 2024	Mar. 14	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the Fourth Quarter Ended October 31, 2023	Dec. 14	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended October 31, 2023	Dec. 14	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-12	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-11	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the First Quarter Ended January 31, 2023	23-03-16	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the Full Year Ended October 31, 2022	23-02-09	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	22-09-08	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	22-06-12	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the Fourth Quarter Ended October 31, 2021	21-12-14	CI
Indies Pharma Jamaica Limited Reports Earnings Results for the Third Quarter Ended July 31, 2021	21-09-13	CI

Chart Indies Pharma Jamaica Limited

Duration

Period

More charts

Company Profile

Indies Pharma Jamaica Limited is a Jamaica-based pharmaceutical company. The Company is engaged in the distribution and retailing of pharmaceutical and auxiliary products. It distributes over 150 prescription and non-prescription or over the counter generic pharmaceutical products for Bioprist Holdings Limited under the Bioprist Pharmaceuticals brand in addition to other products being sold under the orthopedic and joint rehabilitation segment. The Company services customers across all 14 parishes of the island, including over 400 pharmacies, private and public hospitals, and government agencies, including the National Health Fund as well as medical practitioners and directly to individual end users. Its products include Indapamide SR 1.5 milligram (mg), Amlodipine 5mg, Amlodipine 10mg, Amlodipine 5mg + Valsartan 80mg, Amlodipine 5mg + Valsartan 160mg, Amlodipine 10mg + Valsartan 160mg, Valsartan 80mg, Valsartan 160mg, Domperidone 10mg, Tamoxifen 10mg, Enalapril 5mg, and others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
INDIES PHARMA JAMAICA LIMITED	-14.24%	22.7M
CARDINAL HEALTH, INC.	-2.46%	24.26B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+14.23%	8.74B
SINOPHARM GROUP CO. LTD.	+1.47%	8.21B
HUADONG MEDICINE CO., LTD	-32.92%	6.87B
H. LUNDBECK A/S	+18.62%	5.29B
GALENICA AG	+1.10%	4.13B
EBOS GROUP LIMITED	-9.24%	3.79B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-10.20%	3.34B
MEDIPAL HOLDINGS CORPORATION	+7.11%	3.2B